Chinese Clinical Oncology : Impact Factor & More
eISSN: 2304-3873pISSN: 2304-3865
Share this on:
Key Metrics
CiteScore 
4.2
SJR
Q3Oncology
SNIP
1.03
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Chinese Clinical Oncology
Chinese Clinical Oncology Journal Specifications
| Overview | |
| Publisher | AME PUBLISHING COMPANY |
| Language | English |
| Frequency | Quarterly |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 2012 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Chinese Clinical Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Chinese Clinical Oncology
Can recurrence-free survival replace overall survival for resectable esophageal cancer?
- 10 Jun 2026
- Chinese clinical oncology
Toxicity management in thoracic chemoradioimmunotherapy: pirfenidone for low grade pneumonitis and lung fibrosis.
- 1 Jun 2026
- Chinese clinical oncology
Network pharmacology of Sijunzi decoction in pancreatic cancer.
- 28 May 2026
- Chinese clinical oncology
Venetoclax with intensive chemotherapy in acute myeloid leukemia.
- 28 May 2026
- Chinese clinical oncology
Adjuvant CDK4/6 inhibitors and novel therapies in early breast cancer: lessons from monarchE overall survival data.
- 19 May 2026
- Chinese clinical oncology
Efficacy and safety of TAS-102 followed by regorafenib or reverse sequence in later-line treatment of metastatic colorectal cancer: a systematic review and meta-analysis.
- 28 Apr 2026
- Chinese clinical oncology
Can recurrence-free survival replace overall survival for resectable esophageal cancer?
- 10 Jun 2026
- Chinese clinical oncology
Toxicity management in thoracic chemoradioimmunotherapy: pirfenidone for low grade pneumonitis and lung fibrosis.
- 1 Jun 2026
- Chinese clinical oncology
Network pharmacology of Sijunzi decoction in pancreatic cancer.
- 28 May 2026
- Chinese clinical oncology
Venetoclax with intensive chemotherapy in acute myeloid leukemia.
- 28 May 2026
- Chinese clinical oncology
Adjuvant CDK4/6 inhibitors and novel therapies in early breast cancer: lessons from monarchE overall survival data.
- 19 May 2026
- Chinese clinical oncology
Efficacy and safety of TAS-102 followed by regorafenib or reverse sequence in later-line treatment of metastatic colorectal cancer: a systematic review and meta-analysis.
- 28 Apr 2026
- Chinese clinical oncology
FAQs on Chinese Clinical Oncology
How long has Chinese Clinical Oncology been actively publishing? 
What is the publishing frequency of Chinese Clinical Oncology?
How many articles did Chinese Clinical Oncology publish last year?
What is the eISSN & pISSN for Chinese Clinical Oncology?
What is Citescore for Chinese Clinical Oncology?
What is SNIP score for Chinese Clinical Oncology?
What is the SJR for Chinese Clinical Oncology?
Who is the publisher of Chinese Clinical Oncology?
